Author:
Brownstone Nicholas D.,Thibodeaux Quinn G.,Reddy Vidhatha D.,Myers Bridget A.,Chan Stephanie Y.,Bhutani Tina,Liao Wilson
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. World Health Organization. Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed Mar 21, 2020.
2. Gooderham M, Papp K. Clinical trial and registry data. Adverse React Biol. 2018;53:15–27. https://doi.org/10.1159/000478074.
3. Reich K, Ortonne J-P, Gottlieb AB, et al. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab’ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. Br J Dermatol. 2012;167(1):180–90. https://doi.org/10.1111/j.1365-2133.2012.10941.x.
4. Ortonne J-P, Taïeb A, Ormerod AD, et al. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol. 2009;161(5):1190–5. https://doi.org/10.1111/j.1365-2133.2009.09238.x.
5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30566-3.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献